标题
Fibroblast growth factor 23: are we ready to use it in clinical practice?
作者
关键词
-
出版物
JOURNAL OF NEPHROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-04
DOI
10.1007/s40620-020-00715-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
- (2019) Joachim H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pre-analytical stability of FGF23 with the contemporary immunoassays
- (2019) Niek F. Dirks et al. CLINICA CHIMICA ACTA
- Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD
- (2019) Daniel Edmonston et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
- (2018) Amarnath Marthi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
- (2018) Natalia Nowak et al. KIDNEY INTERNATIONAL
- Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23
- (2018) Isao Matsui et al. KIDNEY INTERNATIONAL
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- Biochemical Comparison of 8-hour Haemodialysis and 4-hour Haemodiafiltration, and Two Dialysis Membranes, in a Randomised Cross-over Trial
- (2018) Shi Z. Choo et al. NEPHROLOGY
- Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population
- (2018) Manfred Hecking et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
- (2018) Markus Ketteler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Burosumab Therapy in Children with X-Linked Hypophosphatemia
- (2018) Thomas O. Carpenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23)
- (2018) Josef van Helden et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study
- (2017) Valeria Cernaro et al. JOURNAL OF NEPHROLOGY
- Longitudinal FGF23 Trajectories and Mortality in Patients with CKD
- (2017) Tamara Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
- (2017) Jair Munoz Mendoza et al. KIDNEY INTERNATIONAL
- Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease
- (2017) Chunhua Zhang et al. MEDICINE
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients
- (2017) Kazuomi Yamashita et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease
- (2017) Michael E. Seifert et al. AMERICAN JOURNAL OF NEPHROLOGY
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
- (2016) Yu-Ming Chang et al. Clinical and Experimental Nephrology
- Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
- (2016) Yuichi Takashi et al. ENDOCRINE RESEARCH
- Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
- (2016) Nao Souma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
- (2016) Helen V Alderson et al. NEPHROLOGY
- Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type
- (2016) D. El-Maouche et al. OSTEOPOROSIS INTERNATIONAL
- Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis
- (2015) Julia J. Scialla et al. AMERICAN JOURNAL OF NEPHROLOGY
- Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue
- (2015) Rik Mencke et al. CARDIOVASCULAR RESEARCH
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
- (2015) Jelmer K. Humalda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults
- (2015) Bhupesh Panwar et al. STROKE
- Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis
- (2015) Bracha K. Goldsweig et al. Current Osteoporosis Reports
- Left Ventricular Mass Progression despite Stable Blood Pressure and Kidney Function in Stage 3 Chronic Kidney Disease
- (2014) Michael E. Seifert et al. AMERICAN JOURNAL OF NEPHROLOGY
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
- (2014) Bryan Kestenbaum et al. Circulation-Heart Failure
- Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease
- (2014) Shunsuke Goto et al. Clinical and Experimental Nephrology
- The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
- (2014) E. R. Smith Clinical Journal of the American Society of Nephrology
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
- (2014) Romina di Giuseppe et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Fibroblast growth factor 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies
- (2014) Yunjun Xiao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD
- (2014) G. Tripepi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mortality Prediction Using Modern Peptide Biomarkers in Hemodialysis Patients - A Comparative Analysis
- (2014) Ferruh Artunc et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma FGF23 and the risk of stroke: The Northern Manhattan Study (NOMAS)
- (2014) C. B. Wright et al. NEUROLOGY
- Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
- (2014) Albina Nowak et al. PLoS One
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making
- (2013) Etienne Cavalier et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
- (2013) Anna Jovanovich et al. ATHEROSCLEROSIS
- Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
- (2013) Edward R. Smith et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Single FGF-23 Measurement and Time-Averaged Plasma Phosphate Levels in Hemodialysis Patients
- (2013) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
- (2013) L. C. Baia et al. Clinical Journal of the American Society of Nephrology
- FGF23 concentrations measured using “intact” assays similar but not interchangeable
- (2013) Manish D. Sinha et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
- (2013) Himiko Sugimoto et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study
- (2013) Romina di Giuseppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Effects of Sevelamer in Stage 3 CKD
- (2013) C. D. Chue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
- (2013) Rika Jimbo et al. KIDNEY INTERNATIONAL
- A protective role for FGF-23 in local defence against disrupted arterial wall integrity?
- (2013) Dongxing Zhu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort
- (2013) Adeera Levin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease
- (2013) Annet Bouma-de Krijger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease
- (2013) Christin Spatz et al. NEPHRON CLINICAL PRACTICE
- Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
- (2013) Karolina Lindberg et al. PLoS One
- Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction
- (2013) Gina M. Yanochko et al. TOXICOLOGICAL SCIENCES
- Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
- (2013) Per-Anton Westerberg et al. BMC Nephrology
- Fibroblast growth factor 23
- (2013) Edward R Smith et al. ANNALS OF CLINICAL BIOCHEMISTRY
- FGF23 adds value to risk prediction in patients with chronic kidney disease
- (2012) Edward R. Smith et al. BONE
- Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis
- (2012) Chikako Nakano et al. BONE
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Acute Effects of Very-Low-Protein Diet on FGF23 Levels: A Randomized Study
- (2012) B. Di Iorio et al. Clinical Journal of the American Society of Nephrology
- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis
- (2012) Laure Patrier et al. JOURNAL OF NEPHROLOGY
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Phosphate Binders in Moderate CKD
- (2012) G. A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mineral Metabolites and CKD Progression in African Americans
- (2012) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
- (2012) Mhairi Sigrist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
- (2012) Inger H Bleskestad et al. BMC Nephrology
- Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial
- (2011) Mahmut Ilker Yilmaz et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
- (2010) S. M. Titan et al. Clinical Journal of the American Society of Nephrology
- Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease
- (2010) S. M. Moe et al. Clinical Journal of the American Society of Nephrology
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
- (2010) A. Kirkpantur et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
- (2010) V. M. Brandenburg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
- (2010) T. Isakova et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
- (2010) H. Olauson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation
- (2010) Wacharee Seeherunvong et al. PEDIATRIC TRANSPLANTATION
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
- (2009) E. G. Farrow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study
- (2009) J. H. Ix et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determination of fibroblast growth factor 23
- (2009) A. C Heijboer et al. ANNALS OF CLINICAL BIOCHEMISTRY
- In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis
- (2008) Teruyo Nakatani et al. FASEB JOURNAL
- Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
- (2008) A. Covic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation
- (2008) Murat Bastepe et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More